Lenacapavir, the injectable drug developed by a US-based company, Gilead Sciences, was trialled (tested) in Uganda and South ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

Mathematical models indicate that the worst-case scenario of the Trump administration’s HIV-related cuts could result in 3 ...

A new report by UNAIDS reveals that Zimbabwe stands to save billions of dollars by investing in sexual and reproductive health and rights (SRHR) services ...

Possible changes to President Donald Trump’s big bill of tax breaks and spending cuts are being considered, though most of ...

The Government of Zimbabwe has assured the public that antiretroviral (ARV) medicines will remain available and accessible to all people living with HIV through to the end of 2025. Furthermore, ...

Over 50,000 Nigerians diagnosed with tuberculosis (TB) remain untreated because of insufficient funding and a shortage of ...

The field of HIV treatment has witnessed a significant transformation since the mid-1990s with the introduction of combination antiretroviral therapy ...